Literature DB >> 7776407

Symptoms of the transurethral resection syndrome using glycine as the irrigant.

J Olsson1, A Nilsson, R G Hahn.   

Abstract

We evaluated signs and symptoms of the transurethral resection syndrome recorded during and after 273 transurethral prostatic resections performed at 2 hospitals between 1984 and 1993. Glycine solution was used as the irrigant and ethanol served as a tracer for fluid absorption. The incidence and severity of symptoms that could possibly be related to the syndrome increased progressively as more glycine solution was absorbed. Patients who absorbed 0 to 300 ml. of glycine solution had an average of 1.3 such symptoms. This number increased to 2.3 when 1,001 to 2,000 ml. were absorbed, 3.1 when 2,001 to 3,000 ml. were absorbed and 5.8 for volumes greater than 3,000 ml. Nausea and vomiting occurred significantly more often when 1,001 to 2,000 ml. were absorbed compared to no absorption. Confusion and arterial hypotension were other prominent signs of fluid absorption, whereas hypertension was not. The severity of symptoms was markedly aggravated when more than 3,000 ml. were absorbed. Extravasation resulted in higher risks of bradycardia, hypotension and failed spontaneous diuresis postoperatively than absorption by the intravascular route.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7776407

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Spinal Anesthesia Facilitates the Early Recognition of TUR Syndrome.

Authors:  Sam McGowan-Smyth; Nikhil Vasdev; Shan Gowrie-Mohan
Journal:  Curr Urol       Date:  2016-05-20

2.  A clinical study comparing BIVAP saline vaporization of the prostate with bipolar TURP in patients with prostate volume 30 to 80 mL: Early complications, physiological changes and postoperative follow-up outcomes.

Authors:  Ozgu Aydogdu; Ayhan Karakose; Yusuf Ziya Atesci
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

Review 3.  Prostatic surgery associated acute kidney injury.

Authors:  Elerson Carlos Costalonga; Verônica Torres Costa E Silva; Renato Caires; James Hung; Luis Yu; Emmanuel A Burdmann
Journal:  World J Nephrol       Date:  2014-11-06

4.  Dilutional hypocalcaemia from urological irrigating fluids.

Authors:  R G Hahn
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

5.  A randomized comparison between three types of irrigating fluids during transurethral resection in benign prostatic hyperplasia.

Authors:  Ayman A Yousef; Ghada A Suliman; Osama M Elashry; Mahmoud D Elsharaby; Abd El-Naser K Elgamasy
Journal:  BMC Anesthesiol       Date:  2010-05-28       Impact factor: 2.217

6.  Life-Threatening Laryngeal Edema and Hyponatremia during Hysteroscopy.

Authors:  Barbara Wegmüller; Kerstin Hug; Charlotte Meier Buenzli; Bernd Yuen; Marco Maggiorini; Alain Rudiger
Journal:  Crit Care Res Pract       Date:  2011-03-29

7.  Electrolyte changes: An indirect method to assess irrigation fluid absorption complications during transurethral resection of prostate: A prospective study.

Authors:  Kumkum Gupta; Bhawna Rastogi; Manish Jain; Prashant K Gupta; Deepak Sharma
Journal:  Saudi J Anaesth       Date:  2010-09

8.  Does caval aorta index correlate with central venous pressure in intravascular volume assessment in patients undergoing endoscopic transuretheral resection of prostate?

Authors:  G F El-Baradey; N S El-Shmaa
Journal:  Saudi J Anaesth       Date:  2016 Apr-Jun

9.  The impact of irrigating fluid absorption on blood coagulation in patients undergoing transurethral resection of the prostate: A prospective observational study using rotational thromboelastometry.

Authors:  Hyun-Jung Shin; Hyo-Seok Na; Young-Tae Jeon; Hee-Pyoung Park; Sun-Woo Nam; Jung-Won Hwang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

10.  Fluid volume kinetics of dilutional hyponatremia; a shock syndrome revisited.

Authors:  Robert G Hahn; Tobias Gebäck
Journal:  Clinics (Sao Paulo)       Date:  2014-02       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.